arrow_back Back Filing freshness 10-Q FY 2026 SEC EDGAR

NutriBand Inc.

NTRB
$7.36 ▲ +0.46 (+6.59%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
11 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
9
Health
Poor
Bearish
auto_awesome

Analytical Summary

NutriBand Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $85.7M
Dividend Yield —
Revenue Growth -4.8% ↘
Op. Margin -408.4% ↗
ROIC -98.4% ↗
FCF / Share $-0.44 →
Trailing P/E —
Price / Book 13.4x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

11-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.04M
↓ -4.8% —
Net Income Profit after all expenses
$-8.23M
↑ +21.5% —
Operating Margin Operating profit as % of sales
-408.4%
↑ +15.0% 0th
FCF / Share Free cash flow per share
$-0.44
↑ +0.7% —
Long-Term Debt Long-term obligations
$1.82K
↑ +15.1% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability →
0
Returns ↓
5
Financial Health ↓
7
Cash Quality ↑
42

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 11 years · 43 quarters